HELE Earnings

HELE reported its earnings on 2026-01-08, showcasing a revenue of 512.83M against an estimate of 505.42M, resulting in a 1.47% surprise. The EPS was 1.71, surpassing the expected 1.69 by 1.18%. The stock experienced a -2.4% price change on the earnings day and a -11.43% change over the next five days, reflecting market reactions to the results.

Following HELE's earnings announcement on 2026-01-08, the stock price moved by -2.4% on the day of the release. Over the subsequent five days, it saw a -11.43% change. Historically, HELE's stock price tends to shift by an average of 12.01% in the 10 days leading up to earnings and -3.14% in the 10 days following, providing insight into potential market.

For 2026/Q4, analysts estimate HELE's annual revenue to reach 450.80M, while the EPS is projected at 0.75. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between HELE's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2026 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, HELE's stock price typically moves by 12.01% in the 10 days before its earnings and -3.14% in the 10 days after. For the upcoming 2026/Q4 earnings, analysts expect an EPS of 0.75 and revenue of 450.80M.

The earnings call reveals declining financial metrics, including revenue and EPS, with margin compression and high inventory levels. Despite some optimistic guidance on innovation and brand building, the lack of specific milestones and the emphasis on long-term growth starting in FY '27 suggest short-term challenges. The market may react negatively due to the weak guidance, increased debt, and the absence of immediate positive catalysts, leading to a likely stock price decline in the next two weeks.